Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
RSV-remmer EDP-938 verlaagt viral load en symptomen bij blootgestelde gezonde volwassenen
jul 2022 | Virale infecties